What is the safest way to check current Octreotide pricing?

Use official brand pages first, then confirm the exact cash-pay or insured amount with the prescribing service and dispensing pharmacy.

Does insurance always cover Octreotide?

No. Coverage depends on the specific plan, indication, and whether prior authorization is approved. Some plans may require step therapy or documentation of medical necessity.

Are there manufacturer savings programs for Octreotide?

Many branded peptide therapies offer savings cards or patient assistance programs. Eligibility typically requires commercial insurance and may exclude government programs like Medicare or Medicaid.

Structured page family:Cost guide

Octreotide Cost Guide: Insurance, Cash Pay, and Savings

In the United States, Octreotide costs depend on brand, pharmacy, insurance design, and whether the patient qualifies for manufacturer savings programs.

Active Market

This page is designed for US treatment decisions and uses US-first pricing and savings sources.

Official pricing

Verify current pricing directly on official Sandostatin pages before starting, because list pricing, self-pay offers, and eligibility terms can change.

Cash-pay reality

Official cash-pay pricing varies by pharmacy and dose. Contact multiple pharmacies or use a prescription discount service for current rates.

Insurance coverage

Commercial coverage for Octreotide varies by plan and indication. Prior authorization is commonly required.

Savings and coupons

Manufacturer savings programs may reduce out-of-pocket cost for eligible commercially insured patients.

Prior Authorization

Prior authorization is common and may require documentation of diagnosis, prior treatments, and clinical need.

Price Breakdown

List price (monthly)

~$3,000-$4,000/month (LAR)

Average wholesale price

~$2,800-$3,800/month

Pharmacy acquisition estimate

~$2,500-$3,500/month

Typical negotiated rate

~$2,000-$2,800/month

Price per dose

~$3,000 per 20 mg LAR injection; ~$4,000 per 30 mg

Annual cost at list price

~$36,000-$48,000

Pharmacy Price Comparison

Pharmacy	Price Range	Notes
Specialty pharmacy	$2,800-$4,000/month	Required for LAR
Hospital outpatient	Similar to specialty	May include administration fee

Insurance Coverage Landscape

Commercial plans

~80-90% for approved indications

Medicare Part D

Covered; may be Part B if administered in clinic

Medicaid

Most states cover

VA coverage

On formulary

TRICARE

Covered

Employer plan typical tier

Tier 4-5 specialty; coinsurance 20-40%

Prior Authorization Guide

Required Documentation

•Acromegaly: elevated GH/IGF-1, MRI
•NETs: pathology confirmation, imaging
•Somatostatin receptor imaging (Octreoscan/Ga-68 DOTATATE) if applicable

Common Denial Reasons

•No biomarker confirmation
•Plan requires specialist prescription
•Experimental use

Appeal Template Points

•FDA-approved indication
•Biochemical confirmation
•Tumor imaging documented
•Standard of care

Expected timeline: 3-7 days

Savings Programs and Patient Assistance

Novartis Patient Assistance

manufacturer

Eligibility: Uninsured, ≤400% FPL

Savings: Free

Income limit: ≤400% FPL

Enrollment: moderate

Annual application

Copay assistance

copay

Eligibility: Commercially insured

Savings: May reduce significantly

Income limit: None

Enrollment: simple

Annual cap

Generic and Biosimilar Status

No generic currently available

Expected: No generic LAR expected

Cost by Dose

Dose/Regimen	Monthly	Annual
20 mg LAR monthly	$3,000	$36,000
30 mg LAR monthly	$4,000	$48,000

Annual Cost Projection

Year 1

$0-$48,000

Year 2

$0-$48,000

Year 3

$0-$48,000

Assumptions

•Chronic therapy
•Insurance coverage

Cost-Saving Strategies

1.Apply for Novartis PAP if uninsured
2.Ensure biomarker confirmation for prior auth
3.Short-acting octreotide is cheaper but requires 2-3x daily dosing
4.Work with specialty pharmacy for insurance navigation

International Price Comparison

Country	Price Range	Notes
UK	~£400-600/month (~$500-750)	NHS

Need help comparing octreotide paths?

Use the provider matcher to package treatment interest, insurance, budget, urgency, and state context before you commit to a prescribing path.

Find a octreotide provider

Next Step

Use the cost calculator

Use provider matching when you need help comparing insured and self-pay treatment paths.

Open tool →

Retention Path

Join the Octreotide tracker waitlist

Capture refill timing, weekly dose history, and symptom notes in one planned workflow.

View tracker landing →

Trust Summary

Reviewed 2026-04-27 by PeptideScholar editorial review. This page currently cites 2 official sources.

Pricing, savings eligibility, and coverage rules can change quickly. Verify all current figures and terms directly on official brand pages before acting.

Octreotide Cost FAQ

Sources

1. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.
J Clin Oncol • 2009
Claim type: clinical
View source →
2. FDA Information on Octreotide
FDA • 2026
Claim type: regulatory
View source →

This content is for informational purposes only and does not constitute medical advice.